CJC-1295(No DAC) + Ipamorelin 5mg/5mg – Lyophilised Powder

KEY HIGHLIGHTS

• Purity: >99% (HPLC Tested)
• Form: Lyophilised Powder
• Packaging: Sterile 3ml Vial
• Intended Use: For laboratory research use only. Not for human consumption.
• Storage: Store at 2–8°C (36–46°F). Keep dry, sealed, and protected from light.

CJC-1295(No DAC) + Ipamorelin is a dual-peptide research blend supplied in sterile lyophilized powder form, designed for use in controlled laboratory environments. This combination pairs two well-characterized compounds frequently studied for their roles in growth hormone signaling and endocrine regulation. Ipamorelin, a selective ghrelin receptor (GHS-R1a) agonist, is commonly investigated for its ability to promote growth hormone release, while CJC-1295 (No DAC), a modified growth hormone-releasing hormone (GHRH) analogue, is studied for its role in stimulating endogenous growth hormone secretion. Together, they are often explored in research models examining coordinated activity within the hypothalamic–pituitary axis. Research applications commonly include: growth hormone signaling and secretion dynamics; hypothalamic–pituitary axis and endocrine regulation studies; peptide receptor interaction and pathway analysis; and pulsatile hormone release and signaling pattern research.

DISCLAIMER

FOR RESEARCH USE ONLY.
Not for human consumption, medical, veterinary, or household use.
Products are intended strictly for laboratory and scientific research purposes by qualified professionals only.